ArticleDiagnostics (Basel, Switzerland)2023
ExtRanFS: An Automated Lung Cancer Malignancy Detection System Using Extremely Randomized Feature Selector.
Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Grad-CAM Enhanced Explainable Deep Learning for Multi-Class Lung Cancer Classification Using DE-SAMNet Model.Diagnostics (Basel, Switzerland) · 2026Article
- Optimized Lung Nodule Classification Using CLAHE-Enhanced CT Imaging and Swin Transformer-Based Deep Feature Extraction.Journal of imaging · 2025Article
- Advanced prognostic modeling with deep learning: assessing long-term outcomes in liver transplant recipients from deceased and living donors.Journal of translational medicine · 2025Article
- An optimized convolutional neural network architecture for lung cancer detection.APL bioengineering · 2024Article
- Knowledge, Attitude and Practice of Radiologists Regarding Artificial Intelligence in Medical Imaging.Journal of multidisciplinary healthcare · 2024Article
- Rapid detection of liver metastasis risk in colorectal cancer patients through blood test indicators.Frontiers in oncology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung cancer is an abnormality where the body's cells multiply uncontrollably. The disease can be deadly if not detected in the initial stage. To address this issue, an automated lung cancer malignancy detection (ExtRanFS) framework is developed using transfer learning. We used the IQ-OTH/NCCD dataset gathered from the Iraq Hospital in 2019, encompassing CT scans of patients suffering from various lung cancers and healthy subjects. The annotated dataset consists of CT slices from 110 patients, of which 40 were diagnosed with malignant tumors and 15 with benign tumors. Fifty-five patients were determined to be in good health. All CT images are in DICOM format with a 1mm slice thickness, consisting of 80 to 200 slices at various sides and angles. The proposed system utilized a convolution-based pre-trained VGG16 model as the feature extractor and an Extremely Randomized Tree Classifier as the feature selector. The selected features are fed to the Multi-Layer Perceptron (MLP) Classifier for detecting whether the lung cancer is benign, malignant, or normal. The accuracy, sensitivity, and F1-Score of the proposed framework are 99.09%, 98.33%, and 98.33%, respectively. To evaluate the proposed model, a comparison is performed with other pre-trained models as feature extractors and also with the existing state-of-the-art methodologies as classifiers. From the experimental results, it is evident that the proposed framework outperformed other existing methodologies. This work would be beneficial to both the practitioners and the patients in identifying whether the tumor is benign, malignant, or normal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.